CYP1A2 and hepatocellular carcinoma: CYP3A4 and CYP1A2 have been shown to be efficient in metabolizing aflatoxin B1 (AFB1), a carcinogen implicated in the etiology of hepatocellular carcinoma (HCC) [84].